查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1415358

CT/NG 检测市场：按产品类型、技术和最终用户划分 - 2024-2030 年全球预测

CT/NG Testing Market by Product (Assays & Kits, Instruments & Analyzers), Testing Type (Lab Tests, PoC Tests), Technology, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年CT/NG检测市场规模为16.3亿美元，预计2024年将达17.4亿美元，2030年将达到26.9亿美元，复合年增长率为7.41%。

CT/NG 检测的全球市场

主要市场统计
基准年[2023] 16.3亿美元
预测年份 [2024] 17.4亿美元
预测年份 [2030] 26.9亿美元
复合年增长率（%） 7.41%
CT/NG检查市场-IMG1

CT/NG 检测的重点是准确诊断、管理和预防性性行为感染(STI)，包括披衣菌感染披衣菌 (CT) 和淋病奈瑟菌 (NG)。世界各地披衣菌感染和淋病感染的盛行率不断上升，以及人们对未经治疗的性传染病相关风险的认识不断提高，也迫切需要及时识别和采取适当的治疗方案。诊断技术的进步提供了提高检测准确性并最大限度缩短 CT/NG 感染週转时间的机会。 POC检测套组的开发受到了广泛欢迎，因为它们无需实验室基础设施即可快速获得结果，从而更快地做出临床决策。然而，与先进诊断测试相关的高成本以及各国政府关于诊断测试的法规差异限制了全球产品的普及。然而，政府主导的倡议分子诊断的采用和推广性传播感染筛检计划以促进早期发现和预防与未经治疗的感染疾病相关的併发症的倡议正在推动 CT/NG 检测市场的发展。

区域洞察

对性行为感染感染 (STI) 即时诊断的需求不断增长，披衣菌感染和淋病感染疾病不断上升，以及政府针对早期检测和治疗的倡议，将增加对 CT/NG 检测的需求。在欧盟国家，人们对应对公共卫生挑战的性传染感染预防计画越来越感兴趣，透过监测改善诊断方法的投资正在为 CT/NG 检测市场做出贡献。由于政府加强提高性传染感染意识和改善医疗保健服务的可近性，中东和非洲地区的 CT/NG 检测具有巨大的成长潜力。该地区人口众多，亚太地区政府的教育宣传活动提高了人们对性健康的认识，因此对于 CT/NG 检测市场来说是一个利润丰厚的市场。

FPNV定位矩阵

FPNV定位矩阵对于评估CT/NG检查市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对 CT/NG 检测市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-CT/NG检测市场的市场规模和预测是多少？

2-CT/NG 检测市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些？

3-CT/NG检测市场的技术趋势和法律规范是什么？

4-CT/NG检测市场主要厂商的市场占有率是多少？

5-进入CT/NG检测市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球性行为感染传染感染的盛行率不断上升
      • 提高对未经治疗的感染疾病的影响的认识
      • 对即时 (POC) 测试设备的需求不断增长
    • 抑制因素
      • 与先进诊断设备相关的高成本
    • 机会
      • 政府推动性健康教育的倡议
      • 整合自动化系统以提高工作流程效率
    • 任务
      • 透过 CT/NG 检测发现抗生素抗药性菌株
  • 市场区隔分析
    • 产品：快速部署仪器和分析仪以提供一致的结果
    • 测试类型：CT/NG PoC测试越来越流行
    • 技术：基于聚合酶炼式反应 (PCR) 的 CT/NG 测试的进步，将准确性置于成本和速度之上
    • 最终使用者：医院和诊所现场护理检测的普及
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章 CT/NG 检查市场：依产品分类

  • 检测方法和套件
  • 测量仪器和分析设备

第七章 CT/NG 检查市场（依测试类型）

  • 临床检查
  • 概念验证测试

第八章 CT/NG 检查市场：依技术分类

  • 免疫诊断
  • 恒温核酸增幅技术
  • 聚合酶炼式反应

第 9 章 CT/NG 检查市场：依最终使用者划分

  • 临床实验室
  • 医院和诊所

第十章 北美、南美CT/NG检测市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章 亚太地区CT/NG检测市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东、非洲CT/NG检测市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析
    • 合约、合作和伙伴关係
    • 新产品发布和功能增强
    • 奖项/奖励/扩展

第14章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Binx Health, Inc.
    • Bio-Rad Laboratories, Inc.
    • Bioneer Corporation
    • Danaher Corporation
    • ELITech Group SAS
    • F. Hoffmann-La Roche Ltd.
    • Geneproof AS
    • Genetic Signatures Ltd.
    • Goffin Molecular Technologies BV
    • Hologic, Inc.
    • Meridian Bioscience Inc.
    • Microbiologics, Inc.
    • Molbio Diagnostics Pvt. Ltd.
    • Operon SA
    • PerkinElmer Inc.
    • QIAGEN NV
    • Sansure Biotech Inc.
    • Seegene, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Tianlong Technology Co., Ltd.
    • Vircell SL
    • Visby Medical, Inc.
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-777F3B3232C0

[188 Pages Report] The CT/NG Testing Market size was estimated at USD 1.63 billion in 2023 and expected to reach USD 1.74 billion in 2024, at a CAGR 7.41% to reach USD 2.69 billion by 2030.

Global CT/NG Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.74 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 7.41%
CT/NG Testing Market - IMG1

The CT/NG testing is primarily focused on the accurate diagnosis, management, and prevention of sexually transmitted infections (STIs), including Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). The increasing prevalence of chlamydia and gonorrhea infections worldwide and rising awareness about the risks associated with untreated STIs also fuel the need for timely identification and appropriate treatment options. Technological diagnostics advancements offer opportunities for improving accuracy in detecting CT/NG infections while minimizing turnaround times. The development of POC test kits, allowing rapid results without any need for laboratory infrastructure, has gained immense popularity since it enables faster clinical decision-making. However, high costs associated with advanced diagnostic tests coupled with variations in government regulations across different countries concerning diagnostic tests limit product penetration worldwide. Nevertheless, the growing adoption of molecular diagnostics methods and government-led initiatives to promote STI screening programs to facilitate early detection and prevention of complications associated with untreated infections contribute positively to the growth of the CT/NG testing market.

Regional Insights

A growing demand for point-of-care diagnostics for sexually transmitted infections (STIs), increasing prevalence of chlamydia and gonorrhea infections, and government initiatives targeting early detection and treatment have expanded the need for CT/NG testing. In the EU countries, a rising focus on STI prevention programs to address the public health challenges investments for improving diagnostic methods through research contribute to the CT/NG testing market. The Middle East & Africa region exhibits significant potential for CT/NG testing growth due to increased government efforts towards improving STI awareness and access to healthcare services. With a large population and growing awareness around sexual health following education campaigns by the Asia-Pacific government, the region presents a lucrative CT/NG testing market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CT/NG Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CT/NG Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CT/NG Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Danaher Corporation, ELITech Group SAS, F. Hoffmann-La Roche Ltd., Geneproof A.S., Genetic Signatures Ltd., Goffin Molecular Technologies B.V., Hologic, Inc., Meridian Bioscience Inc., Microbiologics, Inc., Molbio Diagnostics Pvt. Ltd., Operon S.A., PerkinElmer Inc., QIAGEN N.V., Sansure Biotech Inc., Seegene, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tianlong Technology Co., Ltd., Vircell S.L., and Visby Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the CT/NG Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Assays & Kits
    • Instruments & Analyzers
  • Testing Type
    • Lab Tests
    • PoC Tests
  • Technology
    • Immunodiagnostics
    • Isothermal Nucleic Acid Amplification Technology
    • Polymerase Chain Reaction
  • End User
    • Clinical Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the CT/NG Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CT/NG Testing Market?

3. What are the technology trends and regulatory frameworks in the CT/NG Testing Market?

4. What is the market share of the leading vendors in the CT/NG Testing Market?

5. Which modes and strategic moves are suitable for entering the CT/NG Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. CT/NG Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of STIs worldwide
      • 5.1.1.2. Growing awareness about the consequences of untreated infections
      • 5.1.1.3. Rising need for point-of-care (POC) testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with advanced diagnostic equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives for promoting sexual health education
      • 5.1.3.2. Integration of automation systems to enhance workflow efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Emergence of antibiotic-resistant strains by CT/NG testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rapid adoption of instruments and analyzers for providing consistent results
    • 5.2.2. Testing Type: Gaining popularity of PoC tests for CT/NG
    • 5.2.3. Technology: Advancing Polymerase Chain Reaction (PCR)-based CT/NG testing for prioritizing accuracy over cost and speed
    • 5.2.4. End User: Popularity of point-of-care testing for hospital and clinic settings
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. CT/NG Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Assays & Kits
  • 6.3. Instruments & Analyzers

7. CT/NG Testing Market, by Testing Type

  • 7.1. Introduction
  • 7.2. Lab Tests
  • 7.3. PoC Tests

8. CT/NG Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Immunodiagnostics
  • 8.3. Isothermal Nucleic Acid Amplification Technology
  • 8.4. Polymerase Chain Reaction

9. CT/NG Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals & Clinics

10. Americas CT/NG Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CT/NG Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CT/NG Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Bio-Rad Launches Exact Diagnostics CT/NG, STI Run Controls
    • 13.3.3. Award, Recognition, & Expansion
      • 13.3.3.1. Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Becton, Dickinson and Company
    • 14.1.3. Binx Health, Inc.
    • 14.1.4. Bio-Rad Laboratories, Inc.
    • 14.1.5. Bioneer Corporation
    • 14.1.6. Danaher Corporation
    • 14.1.7. ELITech Group SAS
    • 14.1.8. F. Hoffmann-La Roche Ltd.
    • 14.1.9. Geneproof A.S.
    • 14.1.10. Genetic Signatures Ltd.
    • 14.1.11. Goffin Molecular Technologies B.V.
    • 14.1.12. Hologic, Inc.
    • 14.1.13. Meridian Bioscience Inc.
    • 14.1.14. Microbiologics, Inc.
    • 14.1.15. Molbio Diagnostics Pvt. Ltd.
    • 14.1.16. Operon S.A.
    • 14.1.17. PerkinElmer Inc.
    • 14.1.18. QIAGEN N.V.
    • 14.1.19. Sansure Biotech Inc.
    • 14.1.20. Seegene, Inc.
    • 14.1.21. Siemens Healthineers AG
    • 14.1.22. Thermo Fisher Scientific Inc.
    • 14.1.23. Tianlong Technology Co., Ltd.
    • 14.1.24. Vircell S.L.
    • 14.1.25. Visby Medical, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CT/NG TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CT/NG TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CT/NG TESTING MARKET DYNAMICS
  • FIGURE 7. CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 10. CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CT/NG TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CT/NG TESTING MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CT/NG TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. CT/NG TESTING MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CT/NG TESTING MARKET SIZE, BY POC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. CT/NG TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CT/NG TESTING MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. CT/NG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CT/NG TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 187. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. CT/NG TESTING MARKET LICENSE & PRICING